Altmetric, is redefining how research impact is assessed. It has added Clinical Guidelines as a new attention source. This addition is momentous as it will help in understanding how research impacts clinical practice. Adding Clinical Guidelines
enriches its pre-existing attention sources such as social media, patents, and forums. Thus providing a holistic view of research influence. Read more about this new addition on Altmetric Explorer. It is an indicator of the extent to which research translates into clinical recommendations.
Why Tracking Clinical Impact Matters?
The inclusion of Clinical Guidelines as an attention source offers critical insights for stakeholders across the research and healthcare ecosystems:
1. Real-World Applications:
Users can trace how research moves from academic settings to practical implementation.
2. Funding Justification:
Funding bodies can assess the tangible outcomes of their investments, showcasing evidence of research translation into healthcare improvements.
3. Strategic Publishing:
Researchers and institutions can identify journals that frequently contribute to Clinical Guidelines, refining their publication strategies.
“Tracking research referenced in Clinical Guidelines is a major step forward in understanding the impact of that research and its translation into healthcare. This will be of particular interest to medical affairs professionals, research funding bodies, and to academic and clinical researchers and their institutions, helping them better understand the practical applications and long-term impact of their research. By adding Clinical Guidelines data to our data sources, we’re enabling users to see the highest form of clinical impact of medical and health research.”
-Amye Kenall, Vice President of Product at Digital Science.
As Altmetric continues to evolve, its tools will play a pivotal role in advancing evidence-based decision-making across healthcare and research landscapes.
